Cannabis Pharm ApS: Financial statements 2025
CVR: 41811269
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Cannabis Pharm ApS (CVR 41811269) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 37,330 and a net result of DKK -22,748 compared with DKK 87,314 the year before. That is a decrease of 88.6% compared with the year before. Equity in the 2025 report amounted to DKK 78,070. The solvency ratio was 2.5%.
- Gross Profit
- DKK 37,330
- Profit/Loss
- DKK -22,748
- Equity
- DKK 78,070
- Total Assets
- DKK 3,148,005
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 37 t. | -23 t. | 78 t. | - |
| 2024 | - | 329 t. | 87 t. | 101 t. | - |
| 2023 | 205 t. | 22 t. | 17 t. | 14 t. | - |
| 2022 | 0 | -9 t. | -9 t. | -3 t. | - |
Official annual report
How creditworthy is Cannabis Pharm ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Cannabis Pharm ApS has published its annual report for 2024. Gross profit came to DKK 328,532, and the net result was DKK 87,314.
About Cannabis Pharm ApS
Cannabis Pharm ApS is a Danish company of the type Anpartsselskab based in Randers SØ, founded in 2020. The company is registered under the industry Engroshandel med parfumerivarer og kosmetik. The management consists of Morten Nøhr Mortensen. The company is owned by Haldsø Holding ApS and ASMJ ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 37,330 and a net result of DKK -22,748 compared with DKK 87,314 the year before. Equity in the 2025 report amounted to DKK 78,070.